VytronUS racks up $49 mln Series C
VytronUS, a medical device company that develops new technologies that treat cardiac arrhythmias, has secured $49 million in Series C funding. The investors included Apple Tree Partners, NEA, BioStar Ventures and Windham Venture Partners.
29 July 2016•1 min read
